Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-19
2011-12-20
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S269000, C544S319000, C544S311000, C544S242000
Reexamination Certificate
active
08080552
ABSTRACT:
Objects of the present invention are the compounds of formula (I), their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, medicaments containing them and their manufacture, as well as the use of the above compounds in the control or prevention of illnesses such as cancer.
REFERENCES:
patent: 2004/0053908 (2004-03-01), Funahashi et al.
patent: WO 02/32872 (2002-04-01), None
patent: WO2004/014870 (2004-02-01), None
patent: WO2005/051366 (2005-06-01), None
patent: WO2008/077548 (2008-07-01), None
Georges Guy
Koerner Matthias
Kolm Irene
Reiff Ulrike
Schaefer Wolfgang
Hoffmann-LA Roche Inc.
Jean-Louis Samira
Johnston George W.
Padmanabhan Sreeni
Rocha-Tramaloni Patricia S.
LandOfFree
Pyrimidyl derivatives as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidyl derivatives as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidyl derivatives as protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4296375